- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00839839
Egg Freezing Pilot Study
December 1, 2015 updated by: Peter McGovern, MD, University Reproductive Associates
Oocyte Cryopreservation in Assisted Reproduction
University Reproductive Associates is conducting a pilot study to study the technique of egg freezing.
Your participation in this study will provide us with important information to allow us to offer this technology for women wishing to freeze their eggs before cancer treatments.
Your participation will include a standard IVF cycle with your eggs being frozen for a brief period of time and then transferred back to you as usual.
You will receive a significant reduction in your IVF cycle cost.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
Hasbrouck Heights, New Jersey, United States, 07604
- University Reproductive Associates
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- 10 women between the ages of 18-35 inclusive at time of signing Informed Consent Form.
- In good general health off of current medications which may confound response to study medications.
- Desire to seek pregnancy actively during the study period by IVF-ICSI.
- A normal uterine cavity must have been confirmed by either hydrosonogram or hysteroscopy within two years of entering the study.
- Ability to use the required medications.
- Day 3 FSH level < 12 IU/ml
Exclusion Criteria:
- Current pregnancy
- Patients with significant anemia (Hemoglobin < 10 mg/dL).
- Patients enrolled simultaneously into other investigative studies that would interfere with this research study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Oocyte Vitrification
|
All oocytes retrieved will be vitrified (rapidly frozen) after egg retrieval.
The oocytes will then be warmed on the same day and fertilized per standard IVF-ICSI.
Resulting embryos will be transferred back to the patient as per protocol.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Incidence of Biochemical Pregnancy
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Recovery of viable oocytes
Time Frame: 1 year
|
1 year
|
|
incidence of fertilization
Time Frame: one year
|
one year
|
|
embryo development (how many fertilized eggs undergo development to a more advanced stage)
Time Frame: 1 year
|
1 year
|
|
clinical pregnancy (fetal pole visible on transvaginal ultrasound) per cycle
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Peter G. McGovern, MD, Umdnj-Njms
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2009
Primary Completion (Actual)
June 1, 2010
Study Completion (Actual)
February 1, 2011
Study Registration Dates
First Submitted
February 9, 2009
First Submitted That Met QC Criteria
February 9, 2009
First Posted (Estimate)
February 10, 2009
Study Record Updates
Last Update Posted (Estimate)
December 3, 2015
Last Update Submitted That Met QC Criteria
December 1, 2015
Last Verified
December 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB 0120080226
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Yuzuncu Yil UniversityCompletedUnexplained Infertility | Female Infertility | Anovulatory InfertilityTurkey (Türkiye)
Clinical Trials on Oocyte Vitrification
-
Northwell HealthTerminated
-
Instituto Valenciano de Infertilidad, IVI VALENCIACompleted
-
University Hospital, Clermont-FerrandOrigio A/SUnknownOocytes Vitrified at Prophase-I Stage | Oocytes Matured in VitroFrance
-
University Hospital, Clermont-FerrandCompletedInfertility | Infertility, FemaleFrance
-
VitrolifeCompleted
-
Rambam Health Care CampusCompleted
-
Centro de Fertilidad y Reproducción Asistida, PeruCentro de Estudios e Investigaciones en Biología y Medicina ReproductivaRecruiting
-
UMC UtrechtVrije Universiteit BrusselTerminated
-
Conceivable Life SciencesCARE Fertility UKRecruiting
-
Overture LifeRecruiting